APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pregabalin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pregabalin Industry Growth and Trends Forecast to 2032

19 December 2025121 pages

Choose your research edition.

Industry ResearchPregabalin Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pregabalin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pregabalin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pregabalin Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pregabalin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Pregabalin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pregabalin include Zhejiang Huahai Pharmaceutical, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Changzhou Pharmaceutical Factory (CPF), ZCL Chemicals, Vasudha Pharma Chem, Srini Pharmaceuticals, Olon S.p.A. and Maps Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pregabalin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pregabalin market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pregabalin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pregabalin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pregabalin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pregabalin Market by Company

Zhejiang Huahai Pharmaceutical

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Changzhou Pharmaceutical Factory (CPF)

ZCL Chemicals

Vasudha Pharma Chem

Srini Pharmaceuticals

Olon S.p.A.

Maps Laboratories

Laurus Labs

Hikal

Glenmark Life Sciences

Dongbang FTL

Divi’s Laboratories

Divi’s Laboratories

CTX Life Sciences

Chemo Iberica

Bazayan

BAL Pharma

Aurobindo Pharma

ARITE Pharmaceutical

Angels Pharma

Almelo Pvt. Ltd.

AASraw Biochemical Technology

Pregabalin Segment by Type

Capsule

Oral Solution

Tablet

Pregabalin Segment by Application

Hospitals

Clinics

Others

Pregabalin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pregabalin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pregabalin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pregabalin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Oral Solution Table 3. Major Company of Tablet Table 4. Global Pregabalin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pregabalin Sales by Type (2021-2026) & (W Units) Table 6. Global Pregabalin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pregabalin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pregabalin Sales Market Share in Value by Type (2021-2026) Table 9. Global Pregabalin Price by Type (2021-2026) & (US$/Unit) Table 10. Global Pregabalin Sales by Type (2027-2032) & (W Units) Table 11. Global Pregabalin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pregabalin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pregabalin Sales Market Share in Value by Type (2027-2032) Table 14. Global Pregabalin Price by Type (2027-2032) & (US$/Unit) Table 15. North America Pregabalin Sales by Type (2021-2026) & (W Units) Table 16. North America Pregabalin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pregabalin Sales by Type (2021-2026) & (W Units) Table 18. Europe Pregabalin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pregabalin Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Pregabalin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pregabalin Sales by Type (2021-2026) & (W Units) Table 22. Latin America Pregabalin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pregabalin Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Pregabalin Sales by Type (2021-2026) & (US$ Million) Table 25. Pregabalin Industry Trends Table 26. Pregabalin Industry Drivers Table 27. Pregabalin Industry Opportunities and Challenges Table 28. Pregabalin Industry Restraints Table 29. Global Pregabalin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pregabalin Revenue Market Share by Company (2021-2026) Table 31. Global Pregabalin Sales by Company (2021-2026) & (W Units) Table 32. Global Pregabalin Sales Share by Company (2021-2026) Table 33. Global Pregabalin Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Pregabalin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pregabalin Major Company Production Sites and Headquarters Table 36. Global Pregabalin Company, Product Type & Application Table 37. Global Pregabalin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pregabalin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pregabalin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pregabalin Sales by Region (2021-2026) & (W Units) Table 42. Global Pregabalin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pregabalin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pregabalin Sales Market Share in Value by Region (2021-2026) Table 45. Global Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Pregabalin Sales by Region (2027-2032) & (W Units) Table 47. Global Pregabalin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pregabalin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pregabalin Sales Market Share in Value by Region (2027-2032) Table 50. Global Pregabalin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Pregabalin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pregabalin Sales by Application (2021-2026) & (W Units) Table 53. Global Pregabalin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pregabalin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pregabalin Sales Market Share in Value by Application (2021-2026) Table 56. Global Pregabalin Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pregabalin Sales by Application (2027-2032) & (W Units) Table 58. Global Pregabalin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pregabalin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pregabalin Sales Market Share in Value by Application (2027-2032) Table 61. Global Pregabalin Price by Application (2027-2032) & (US$/Unit) Table 62. North America Pregabalin Sales by Application (2021-2026) & (W Units) Table 63. North America Pregabalin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pregabalin Sales by Application (2021-2026) & (W Units) Table 65. Europe Pregabalin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pregabalin Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Pregabalin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pregabalin Sales by Application (2021-2026) & (W Units) Table 69. Latin America Pregabalin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pregabalin Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Pregabalin Sales by Application (2021-2026) & (US$ Million) Table 72. Zhejiang Huahai Pharmaceutical Company Information Table 73. Zhejiang Huahai Pharmaceutical Business Overview Table 74. Zhejiang Huahai Pharmaceutical Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio Table 76. Zhejiang Huahai Pharmaceutical Recent Development Table 77. Teva Pharmaceutical Industries Company Information Table 78. Teva Pharmaceutical Industries Business Overview Table 79. Teva Pharmaceutical Industries Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Teva Pharmaceutical Industries Pregabalin Product Portfolio Table 81. Teva Pharmaceutical Industries Recent Development Table 82. Sun Pharmaceutical Industries Company Information Table 83. Sun Pharmaceutical Industries Business Overview Table 84. Sun Pharmaceutical Industries Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sun Pharmaceutical Industries Pregabalin Product Portfolio Table 86. Sun Pharmaceutical Industries Recent Development Table 87. Changzhou Pharmaceutical Factory (CPF) Company Information Table 88. Changzhou Pharmaceutical Factory (CPF) Business Overview Table 89. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio Table 91. Changzhou Pharmaceutical Factory (CPF) Recent Development Table 92. ZCL Chemicals Company Information Table 93. ZCL Chemicals Business Overview Table 94. ZCL Chemicals Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. ZCL Chemicals Pregabalin Product Portfolio Table 96. ZCL Chemicals Recent Development Table 97. Vasudha Pharma Chem Company Information Table 98. Vasudha Pharma Chem Business Overview Table 99. Vasudha Pharma Chem Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Vasudha Pharma Chem Pregabalin Product Portfolio Table 101. Vasudha Pharma Chem Recent Development Table 102. Srini Pharmaceuticals Company Information Table 103. Srini Pharmaceuticals Business Overview Table 104. Srini Pharmaceuticals Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Srini Pharmaceuticals Pregabalin Product Portfolio Table 106. Srini Pharmaceuticals Recent Development Table 107. Olon S.p.A. Company Information Table 108. Olon S.p.A. Business Overview Table 109. Olon S.p.A. Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Olon S.p.A. Pregabalin Product Portfolio Table 111. Olon S.p.A. Recent Development Table 112. Maps Laboratories Company Information Table 113. Maps Laboratories Business Overview Table 114. Maps Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Maps Laboratories Pregabalin Product Portfolio Table 116. Maps Laboratories Recent Development Table 117. Laurus Labs Company Information Table 118. Laurus Labs Business Overview Table 119. Laurus Labs Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Laurus Labs Pregabalin Product Portfolio Table 121. Laurus Labs Recent Development Table 122. Hikal Company Information Table 123. Hikal Business Overview Table 124. Hikal Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Hikal Pregabalin Product Portfolio Table 126. Hikal Recent Development Table 127. Glenmark Life Sciences Company Information Table 128. Glenmark Life Sciences Business Overview Table 129. Glenmark Life Sciences Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Glenmark Life Sciences Pregabalin Product Portfolio Table 131. Glenmark Life Sciences Recent Development Table 132. Dongbang FTL Company Information Table 133. Dongbang FTL Business Overview Table 134. Dongbang FTL Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Dongbang FTL Pregabalin Product Portfolio Table 136. Dongbang FTL Recent Development Table 137. Divi’s Laboratories Company Information Table 138. Divi’s Laboratories Business Overview Table 139. Divi’s Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Divi’s Laboratories Pregabalin Product Portfolio Table 141. Divi’s Laboratories Recent Development Table 142. Divi’s Laboratories Company Information Table 143. Divi’s Laboratories Business Overview Table 144. Divi’s Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Divi’s Laboratories Pregabalin Product Portfolio Table 146. Divi’s Laboratories Recent Development Table 147. CTX Life Sciences Company Information Table 148. CTX Life Sciences Business Overview Table 149. CTX Life Sciences Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. CTX Life Sciences Pregabalin Product Portfolio Table 151. CTX Life Sciences Recent Development Table 152. Chemo Iberica Company Information Table 153. Chemo Iberica Business Overview Table 154. Chemo Iberica Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Chemo Iberica Pregabalin Product Portfolio Table 156. Chemo Iberica Recent Development Table 157. Bazayan Company Information Table 158. Bazayan Business Overview Table 159. Bazayan Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Bazayan Pregabalin Product Portfolio Table 161. Bazayan Recent Development Table 162. BAL Pharma Company Information Table 163. BAL Pharma Business Overview Table 164. BAL Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. BAL Pharma Pregabalin Product Portfolio Table 166. BAL Pharma Recent Development Table 167. Aurobindo Pharma Company Information Table 168. Aurobindo Pharma Business Overview Table 169. Aurobindo Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Aurobindo Pharma Pregabalin Product Portfolio Table 171. Aurobindo Pharma Recent Development Table 172. ARITE Pharmaceutical Company Information Table 173. ARITE Pharmaceutical Business Overview Table 174. ARITE Pharmaceutical Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. ARITE Pharmaceutical Pregabalin Product Portfolio Table 176. ARITE Pharmaceutical Recent Development Table 177. Angels Pharma Company Information Table 178. Angels Pharma Business Overview Table 179. Angels Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Angels Pharma Pregabalin Product Portfolio Table 181. Angels Pharma Recent Development Table 182. Almelo Pvt. Ltd. Company Information Table 183. Almelo Pvt. Ltd. Business Overview Table 184. Almelo Pvt. Ltd. Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Almelo Pvt. Ltd. Pregabalin Product Portfolio Table 186. Almelo Pvt. Ltd. Recent Development Table 187. AASraw Biochemical Technology Company Information Table 188. AASraw Biochemical Technology Business Overview Table 189. AASraw Biochemical Technology Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. AASraw Biochemical Technology Pregabalin Product Portfolio Table 191. AASraw Biochemical Technology Recent Development Table 192. North America Pregabalin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 193. North America Pregabalin Sales by Country (2021-2026) & (W Units) Table 194. North America Pregabalin Sales Market Share by Country (2021-2026) Table 195. North America Pregabalin Sales Forecast by Country (2027-2032) & (W Units) Table 196. North America Pregabalin Sales Market Share Forecast by Country (2027-2032) Table 197. North America Pregabalin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. North America Pregabalin Market Size by Country (2021-2026) & (US$ Million) Table 199. North America Pregabalin Market Share by Country (2021-2026) Table 200. North America Pregabalin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. North America Pregabalin Market Share Forecast by Country (2027-2032) Table 202. Europe Pregabalin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 203. Europe Pregabalin Sales by Country (2021-2026) & (W Units) Table 204. Europe Pregabalin Sales Market Share by Country (2021-2026) Table 205. Europe Pregabalin Sales Forecast by Country (2027-2032) & (W Units) Table 206. Europe Pregabalin Sales Market Share Forecast by Country (2027-2032) Table 207. Europe Pregabalin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Europe Pregabalin Market Size by Country (2021-2026) & (US$ Million) Table 209. Europe Pregabalin Market Share by Country (2021-2026) Table 210. Europe Pregabalin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Europe Pregabalin Market Share Forecast by Country (2027-2032) Table 212. Asia-Pacific Pregabalin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 213. Asia-Pacific Pregabalin Sales by Country (2021-2026) & (W Units) Table 214. Asia-Pacific Pregabalin Sales Market Share by Country (2021-2026) Table 215. Asia-Pacific Pregabalin Sales Forecast by Country (2027-2032) & (W Units) Table 216. Asia-Pacific Pregabalin Sales Market Share Forecast by Country (2027-2032) Table 217. Asia-Pacific Pregabalin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 218. Asia-Pacific Pregabalin Market Size by Country (2021-2026) & (US$ Million) Table 219. Asia-Pacific Pregabalin Market Share by Country (2021-2026) Table 220. Asia-Pacific Pregabalin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 221. Asia-Pacific Pregabalin Market Share Forecast by Country (2027-2032) Table 222. Latin America Pregabalin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 223. Latin America Pregabalin Sales by Country (2021-2026) & (W Units) Table 224. Latin America Pregabalin Sales Market Share by Country (2021-2026) Table 225. Latin America Pregabalin Sales Forecast by Country (2027-2032) & (W Units) Table 226. Latin America Pregabalin Sales Market Share Forecast by Country (2027-2032) Table 227. Latin America Pregabalin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 228. Latin America Pregabalin Market Size by Country (2021-2026) & (US$ Million) Table 229. Latin America Pregabalin Market Share by Country (2021-2026) Table 230. Latin America Pregabalin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 231. Latin America Pregabalin Market Share Forecast by Country (2027-2032) Table 232. Middle East and Africa Pregabalin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 233. Middle East and Africa Pregabalin Sales by Country (2021-2026) & (W Units) Table 234. Middle East and Africa Pregabalin Sales Market Share by Country (2021-2026) Table 235. Middle East and Africa Pregabalin Sales Forecast by Country (2027-2032) & (W Units) Table 236. Middle East and Africa Pregabalin Sales Market Share Forecast by Country (2027-2032) Table 237. Middle East and Africa Pregabalin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 238. Middle East and Africa Pregabalin Market Size by Country (2021-2026) & (US$ Million) Table 239. Middle East and Africa Pregabalin Market Share by Country (2021-2026) Table 240. Middle East and Africa Pregabalin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 241. Middle East and Africa Pregabalin Market Share Forecast by Country (2027-2032) Table 242. Key Raw Materials Table 243. Raw Materials Key Suppliers Table 244. Pregabalin Distributors List Table 245. Pregabalin Customers List Table 246. Research Programs/Design for This Report Table 247. Authors List of This Report Table 248. Secondary Sources Table 249. Primary Sources List of Figures Figure 1. Pregabalin Image Figure 2. Global Pregabalin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pregabalin Market Size (2021-2032) & (US$ Million) Figure 4. Global Pregabalin Sales (2021-2032) & (W Units) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (W Units) Figure 7. Oral Solution Image Figure 8. Global Oral Solution Sales YoY Growth (2021-2032) & (W Units) Figure 9. Tablet Image Figure 10. Global Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Pregabalin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pregabalin Market Share by Type 2025 VS 2032 Figure 13. North America Pregabalin Sales Market Share in Volume by Type in 2025 Figure 14. North America Pregabalin Sales Market Share in Value by Type in 2025 Figure 15. Europe Pregabalin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pregabalin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pregabalin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pregabalin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pregabalin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pregabalin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pregabalin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pregabalin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pregabalin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (W Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Pregabalin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pregabalin Market Share by Application 2025 VS 2032 Figure 33. North America Pregabalin Sales Market Share in Volume by Application in 2025 Figure 34. North America Pregabalin Sales Market Share in Value by Application in 2025 Figure 35. Europe Pregabalin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pregabalin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pregabalin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pregabalin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pregabalin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pregabalin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pregabalin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pregabalin Sales Market Share in Value by Application in 2025 Figure 43. North America Pregabalin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Pregabalin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pregabalin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pregabalin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pregabalin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Pregabalin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pregabalin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pregabalin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pregabalin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Pregabalin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pregabalin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pregabalin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pregabalin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Pregabalin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pregabalin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pregabalin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pregabalin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Pregabalin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pregabalin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pregabalin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pregabalin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pregabalin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Changzhou Pharmaceutical Factory (CPF)
  • ZCL Chemicals
  • Vasudha Pharma Chem
  • Srini Pharmaceuticals
  • Olon S.p.A.
  • Maps Laboratories
  • Laurus Labs
  • Hikal
  • Glenmark Life Sciences
  • Dongbang FTL
  • Divi’s Laboratories
  • Divi’s Laboratories
  • CTX Life Sciences
  • Chemo Iberica
  • Bazayan
  • BAL Pharma
  • Aurobindo Pharma
  • ARITE Pharmaceutical
  • Angels Pharma
  • Almelo Pvt. Ltd.
  • AASraw Biochemical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pregabalin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pregabalin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pregabalin Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Oral Solution
  8. 1.3.3 Tablet
  9. 1.4 Global Pregabalin Market Size by Type
  10. 1.4.1 Global Pregabalin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pregabalin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pregabalin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pregabalin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pregabalin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pregabalin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pregabalin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pregabalin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pregabalin Industry Trends
  2. 2.2 Pregabalin Industry Drivers
  3. 2.3 Pregabalin Industry Opportunities and Challenges
  4. 2.4 Pregabalin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pregabalin Revenue (2021-2026)
  2. 3.2 Global Top Players by Pregabalin Sales (2021-2026)
  3. 3.3 Global Top Players by Pregabalin Price (2021-2026)
  4. 3.4 Global Pregabalin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pregabalin Major Company Production Sites & Headquarters
  6. 3.6 Global Pregabalin Company, Product Type & Application
  7. 3.7 Global Pregabalin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pregabalin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pregabalin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pregabalin Tier 1, Tier 2, and Tier 3
4 Pregabalin Regional Status and Outlook
  1. 4.1 Global Pregabalin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pregabalin Historic Market Size by Region
  3. 4.2.1 Global Pregabalin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pregabalin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pregabalin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pregabalin Forecasted Market Size by Region
  7. 4.3.1 Global Pregabalin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pregabalin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pregabalin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pregabalin by Application
  1. 5.1 Pregabalin Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pregabalin Market Size by Application
  6. 5.2.1 Global Pregabalin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pregabalin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pregabalin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pregabalin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pregabalin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pregabalin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pregabalin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pregabalin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Huahai Pharmaceutical
  2. 6.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio
  6. 6.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 6.2 Teva Pharmaceutical Industries
  8. 6.2.1 Teva Pharmaceutical Industries Company Information
  9. 6.2.2 Teva Pharmaceutical Industries Business Overview
  10. 6.2.3 Teva Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceutical Industries Pregabalin Product Portfolio
  12. 6.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 6.3 Sun Pharmaceutical Industries
  14. 6.3.1 Sun Pharmaceutical Industries Company Information
  15. 6.3.2 Sun Pharmaceutical Industries Business Overview
  16. 6.3.3 Sun Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Industries Pregabalin Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 6.4 Changzhou Pharmaceutical Factory (CPF)
  20. 6.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
  21. 6.4.2 Changzhou Pharmaceutical Factory (CPF) Business Overview
  22. 6.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio
  24. 6.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Developments
  25. 6.5 ZCL Chemicals
  26. 6.5.1 ZCL Chemicals Company Information
  27. 6.5.2 ZCL Chemicals Business Overview
  28. 6.5.3 ZCL Chemicals Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ZCL Chemicals Pregabalin Product Portfolio
  30. 6.5.5 ZCL Chemicals Recent Developments
  31. 6.6 Vasudha Pharma Chem
  32. 6.6.1 Vasudha Pharma Chem Company Information
  33. 6.6.2 Vasudha Pharma Chem Business Overview
  34. 6.6.3 Vasudha Pharma Chem Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vasudha Pharma Chem Pregabalin Product Portfolio
  36. 6.6.5 Vasudha Pharma Chem Recent Developments
  37. 6.7 Srini Pharmaceuticals
  38. 6.7.1 Srini Pharmaceuticals Company Information
  39. 6.7.2 Srini Pharmaceuticals Business Overview
  40. 6.7.3 Srini Pharmaceuticals Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Srini Pharmaceuticals Pregabalin Product Portfolio
  42. 6.7.5 Srini Pharmaceuticals Recent Developments
  43. 6.8 Olon S.p.A.
  44. 6.8.1 Olon S.p.A. Company Information
  45. 6.8.2 Olon S.p.A. Business Overview
  46. 6.8.3 Olon S.p.A. Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Olon S.p.A. Pregabalin Product Portfolio
  48. 6.8.5 Olon S.p.A. Recent Developments
  49. 6.9 Maps Laboratories
  50. 6.9.1 Maps Laboratories Company Information
  51. 6.9.2 Maps Laboratories Business Overview
  52. 6.9.3 Maps Laboratories Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Maps Laboratories Pregabalin Product Portfolio
  54. 6.9.5 Maps Laboratories Recent Developments
  55. 6.10 Laurus Labs
  56. 6.10.1 Laurus Labs Company Information
  57. 6.10.2 Laurus Labs Business Overview
  58. 6.10.3 Laurus Labs Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Laurus Labs Pregabalin Product Portfolio
  60. 6.10.5 Laurus Labs Recent Developments
  61. 6.11 Hikal
  62. 6.11.1 Hikal Company Information
  63. 6.11.2 Hikal Business Overview
  64. 6.11.3 Hikal Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hikal Pregabalin Product Portfolio
  66. 6.11.5 Hikal Recent Developments
  67. 6.12 Glenmark Life Sciences
  68. 6.12.1 Glenmark Life Sciences Company Information
  69. 6.12.2 Glenmark Life Sciences Business Overview
  70. 6.12.3 Glenmark Life Sciences Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Glenmark Life Sciences Pregabalin Product Portfolio
  72. 6.12.5 Glenmark Life Sciences Recent Developments
  73. 6.13 Dongbang FTL
  74. 6.13.1 Dongbang FTL Company Information
  75. 6.13.2 Dongbang FTL Business Overview
  76. 6.13.3 Dongbang FTL Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Dongbang FTL Pregabalin Product Portfolio
  78. 6.13.5 Dongbang FTL Recent Developments
  79. 6.14 Divi’s Laboratories
  80. 6.14.1 Divi’s Laboratories Company Information
  81. 6.14.2 Divi’s Laboratories Business Overview
  82. 6.14.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Divi’s Laboratories Pregabalin Product Portfolio
  84. 6.14.5 Divi’s Laboratories Recent Developments
  85. 6.15 Divi’s Laboratories
  86. 6.15.1 Divi’s Laboratories Company Information
  87. 6.15.2 Divi’s Laboratories Business Overview
  88. 6.15.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Divi’s Laboratories Pregabalin Product Portfolio
  90. 6.15.5 Divi’s Laboratories Recent Developments
  91. 6.16 CTX Life Sciences
  92. 6.16.1 CTX Life Sciences Company Information
  93. 6.16.2 CTX Life Sciences Business Overview
  94. 6.16.3 CTX Life Sciences Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CTX Life Sciences Pregabalin Product Portfolio
  96. 6.16.5 CTX Life Sciences Recent Developments
  97. 6.17 Chemo Iberica
  98. 6.17.1 Chemo Iberica Company Information
  99. 6.17.2 Chemo Iberica Business Overview
  100. 6.17.3 Chemo Iberica Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Chemo Iberica Pregabalin Product Portfolio
  102. 6.17.5 Chemo Iberica Recent Developments
  103. 6.18 Bazayan
  104. 6.18.1 Bazayan Company Information
  105. 6.18.2 Bazayan Business Overview
  106. 6.18.3 Bazayan Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Bazayan Pregabalin Product Portfolio
  108. 6.18.5 Bazayan Recent Developments
  109. 6.19 BAL Pharma
  110. 6.19.1 BAL Pharma Company Information
  111. 6.19.2 BAL Pharma Business Overview
  112. 6.19.3 BAL Pharma Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 BAL Pharma Pregabalin Product Portfolio
  114. 6.19.5 BAL Pharma Recent Developments
  115. 6.20 Aurobindo Pharma
  116. 6.20.1 Aurobindo Pharma Company Information
  117. 6.20.2 Aurobindo Pharma Business Overview
  118. 6.20.3 Aurobindo Pharma Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Aurobindo Pharma Pregabalin Product Portfolio
  120. 6.20.5 Aurobindo Pharma Recent Developments
  121. 6.21 ARITE Pharmaceutical
  122. 6.21.1 ARITE Pharmaceutical Company Information
  123. 6.21.2 ARITE Pharmaceutical Business Overview
  124. 6.21.3 ARITE Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 ARITE Pharmaceutical Pregabalin Product Portfolio
  126. 6.21.5 ARITE Pharmaceutical Recent Developments
  127. 6.22 Angels Pharma
  128. 6.22.1 Angels Pharma Company Information
  129. 6.22.2 Angels Pharma Business Overview
  130. 6.22.3 Angels Pharma Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Angels Pharma Pregabalin Product Portfolio
  132. 6.22.5 Angels Pharma Recent Developments
  133. 6.23 Almelo Pvt. Ltd.
  134. 6.23.1 Almelo Pvt. Ltd. Company Information
  135. 6.23.2 Almelo Pvt. Ltd. Business Overview
  136. 6.23.3 Almelo Pvt. Ltd. Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Almelo Pvt. Ltd. Pregabalin Product Portfolio
  138. 6.23.5 Almelo Pvt. Ltd. Recent Developments
  139. 6.24 AASraw Biochemical Technology
  140. 6.24.1 AASraw Biochemical Technology Company Information
  141. 6.24.2 AASraw Biochemical Technology Business Overview
  142. 6.24.3 AASraw Biochemical Technology Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 AASraw Biochemical Technology Pregabalin Product Portfolio
  144. 6.24.5 AASraw Biochemical Technology Recent Developments
7 North America by Country
  1. 7.1 North America Pregabalin Sales by Country
  2. 7.1.1 North America Pregabalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pregabalin Sales by Country (2021-2026)
  4. 7.1.3 North America Pregabalin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pregabalin Market Size by Country
  6. 7.2.1 North America Pregabalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pregabalin Market Size by Country (2021-2026)
  8. 7.2.3 North America Pregabalin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pregabalin Sales by Country
  2. 8.1.1 Europe Pregabalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pregabalin Sales by Country (2021-2026)
  4. 8.1.3 Europe Pregabalin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pregabalin Market Size by Country
  6. 8.2.1 Europe Pregabalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pregabalin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pregabalin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pregabalin Sales by Country
  2. 9.1.1 Asia-Pacific Pregabalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pregabalin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pregabalin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pregabalin Market Size by Country
  6. 9.2.1 Asia-Pacific Pregabalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pregabalin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pregabalin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pregabalin Sales by Country
  2. 10.1.1 South America Pregabalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pregabalin Sales by Country (2021-2026)
  4. 10.1.3 South America Pregabalin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pregabalin Market Size by Country
  6. 10.2.1 South America Pregabalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pregabalin Market Size by Country (2021-2026)
  8. 10.2.3 South America Pregabalin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pregabalin Sales by Country
  2. 11.1.1 Middle East and Africa Pregabalin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pregabalin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pregabalin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pregabalin Market Size by Country
  6. 11.2.1 Middle East and Africa Pregabalin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pregabalin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pregabalin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pregabalin Value Chain Analysis
  2. 12.1.1 Pregabalin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pregabalin Production Mode & Process
  7. 12.2 Pregabalin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pregabalin Distributors
  10. 12.2.3 Pregabalin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst